Call for Collaborative Research Proposals in Drug Discovery

This document is a call for collaborative research proposals aimed at advancing drug discovery through innovative approaches targeting human diseases with small molecule drugs. The initiative invites proposals from the academic community to utilize Schrödinger's proprietary physics-based computational platform, which has been instrumental in developing clinical-stage therapeutics. The Request for Proposals (RFP) seeks to support translational research that identifies novel drug targets and addresses unmet medical needs. Selected projects will benefit from access to Schrödinger's computational tools, expertise in drug discovery, and potential funding for experimental work. The document outlines the criteria for proposal evaluation, emphasizing scientific merit, feasibility, and clinical need. It also details the application process, including the submission of a Letter of Intent and a full application, with a deadline for submission set for February 18th, 2024. Additionally, it specifies the types of projects that qualify and the benefits of collaboration with Schrödinger.